glp 1 agonist new drug GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness How GLP-1 Receptor Agonists Evolved
Description
JAMA Surg 158(10):10031011 Miras AD et al (2019) Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial
The early phase is thought to be mediated by neuroendocrine pathways, including vagal afferents and enteric neurotransmitters such as acetylcholine and gastrin-releasing peptide
For instance, diabetes-induced chronic hyperglycemia, persistently-elevated free fatty acids and hyperinsulinemia all could lead to cardiac hypertrophy, intramyocardial inflammation, impaired mitochondrial function, and ultimately HF [4]
Wegovy (semaglutide 2.4mg) is an FDA-approved drug that has undergone FDA review for safety, effectiveness, and manufacturing quality
The findings indicate that the reduction in blood pressure was both weight-dependent and independent of weight loss
